BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Cancer Lett. 2008;270:77-86. [PMID: 18554781 DOI: 10.1016/j.canlet.2008.04.038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun B, Zhang Y, Zhang M, Liu R, Yang W. Gene therapy targeting miR‑212‑3p exerts therapeutic effects on MAFLD similar to those of exercise. Int J Mol Med 2023;51:16. [PMID: 36633140 DOI: 10.3892/ijmm.2023.5219] [Reference Citation Analysis]
2 Kaur KK, K. Allahbadia GN, Singh M. Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development; and their Therapeutic Applications in Cancers - A Narrative Review. J Pharm Nutr Sci 2022;12:35-53. [DOI: 10.29169/1927-5951.2022.12.04] [Reference Citation Analysis]
3 Jang JY, Im E, Choi YH, Kim ND. Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review. IJMS 2022;23:7184. [DOI: 10.3390/ijms23137184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Shen D, Zeng Y, Zhang W, Li Y, Zhu J, Liu Z, Yan Z, Huang JA. Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway. Eur J Pharmacol 2022;:174925. [PMID: 35364069 DOI: 10.1016/j.ejphar.2022.174925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Zhang Y, Shi X, Li J, Wang L, Xie C, Wang Y. Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway. Front Oncol 2022;12:836333. [DOI: 10.3389/fonc.2022.836333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 di Gregorio MC, Cautela J, Galantini L. Physiology and Physical Chemistry of Bile Acids. Int J Mol Sci 2021;22:1780. [PMID: 33579036 DOI: 10.3390/ijms22041780] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
7 Bechynska K, Daskova N, Vrzackova N, Harant K, Heczková M, Podzimkova K, Bratova M, Dankova H, Berkova Z, Kosek V, Zelenka J, Hajslova J, Sedlacek R, Suttnar J, Hlavackova A, Bartonova L, Cahova M. The effect of ω-3 polyunsaturated fatty acids on the liver lipidome, proteome and bile acid profile: parenteral versus enteral administration. Sci Rep 2019;9:19097. [PMID: 31836843 DOI: 10.1038/s41598-019-54225-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Goossens J, Bailly C. Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy. Pharmacology & Therapeutics 2019;203:107396. [DOI: 10.1016/j.pharmthera.2019.107396] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
9 Agarwal DS, Singh RP, Lohitesh K, Jha PN, Chowdhury R, Sakhuja R. Synthesis and evaluation of bile acid amides of $$\alpha $$ α -cyanostilbenes as anticancer agents. Mol Divers 2018;22:305-21. [DOI: 10.1007/s11030-017-9797-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
10 Pang X, Yin SS, Yu HY, Zhang Y, Wang T, Hu LM, Han LF. Prenylated flavonoids and dihydrophenanthrenes from the leaves of Epimedium brevicornu and their cytotoxicity against HepG2 cells. Nat Prod Res 2018;32:2253-9. [PMID: 29172686 DOI: 10.1080/14786419.2017.1405410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Magee N, Zhang Y. Role of early growth response 1 in liver metabolism and liver cancer. Hepatoma Res 2017;3:268-77. [PMID: 29607419 DOI: 10.20517/2394-5079.2017.36] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
12 Xu M, Zhao Q, Shao D, Liu H, Qi J, Qin C. Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1. Biomed Res Int 2017;2017:1465912. [PMID: 28261604 DOI: 10.1155/2017/1465912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
13 Hwang SR, Kim IJ, Park JW. Formulations of deoxycholic for therapy: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 2015;25:1423-40. [DOI: 10.1517/13543776.2016.1102888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
14 Brossard D, Lechevrel M, El Kihel L, Quesnelle C, Khalid M, Moslemi S, Reimund JM. Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines. Eur J Med Chem 2014;86:279-90. [PMID: 25173827 DOI: 10.1016/j.ejmech.2014.07.080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
15 Májer F, Sharma R, Mullins C, Keogh L, Phipps S, Duggan S, Kelleher D, Keely S, Long A, Radics G, Wang J, Gilmer JF. New highly toxic bile acids derived from deoxycholic acid, chenodeoxycholic acid and lithocholic acid. Bioorganic & Medicinal Chemistry 2014;22:256-68. [DOI: 10.1016/j.bmc.2013.11.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jang ES, Yoon J, Lee S, Lee S, Lee J, Yu SJ, Kim YJ, Lee H, Kim CY. Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation. J Cancer Res Clin Oncol 2014;140:133-44. [DOI: 10.1007/s00432-013-1554-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
17 Miah S, Zadeh SNM, Yuan X, Li W. Expression of Egr1 and p53 in human carotid plaques and apoptosis induced by 7-oxysterol or p53. Experimental and Toxicologic Pathology 2013;65:677-82. [DOI: 10.1016/j.etp.2012.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
18 Salvador JA, Carvalho JF, Neves MA, Silvestre SM, Leitão AJ, Silva MM, Sá e Melo ML. Anticancer steroids: linking natural and semi-synthetic compounds. Nat Prod Rep 2013;30:324-74. [PMID: 23151898 DOI: 10.1039/c2np20082a] [Cited by in Crossref: 180] [Cited by in F6Publishing: 186] [Article Influence: 18.0] [Reference Citation Analysis]
19 Thomes PG, Osna NA, Davis JS, Donohue TM Jr. Cellular steatosis in ethanol oxidizing-HepG2 cells is partially controlled by the transcription factor, early growth response-1. Int J Biochem Cell Biol 2013;45:454-63. [PMID: 23103837 DOI: 10.1016/j.biocel.2012.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
20 Perrone D, Bortolini O, Fogagnolo M, Marchesi E, Mari L, Massarenti C, Navacchia ML, Sforza F, Varani K, Capobianco ML. Synthesis and in vitro cytotoxicity of deoxyadenosine–bile acid conjugates linked with 1,2,3-triazole. New J Chem 2013;37:3559. [DOI: 10.1039/c3nj00513e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
21 Whitlock NC, Baek SJ. The anticancer effects of resveratrol: modulation of transcription factors. Nutr Cancer 2012;64:493-502. [PMID: 22482424 DOI: 10.1080/01635581.2012.667862] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 8.5] [Reference Citation Analysis]
22 Hossain MA, Kim DH, Jang JY, Kang YJ, Yoon JH, Moon JO, Chung HY, Kim GY, Choi YH, Copple BL, Kim ND. Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. Int J Oncol. 2012;40:1298-1304. [PMID: 22179060 DOI: 10.3892/ijo.2011.1304] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
23 Tillman EM, Helms RA, Black DD. Eicosapentaenoic Acid and Docosahexaenoic Acid Synergistically Attenuate Bile Acid–Induced Hepatocellular Apoptosis. JPEN J Parenter Enteral Nutr 2012;36:36-42. [DOI: 10.1177/0148607111409588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
24 Qi H, Xue B. Role of early growth response 1 in liver injury. Shijie Huaren Xiaohua Zazhi 2011; 19(18): 1914-1921 [DOI: 10.11569/wcjd.v19.i18.1914] [Reference Citation Analysis]
25 Whitlock NC, Bahn JH, Lee SH, Eling TE, Baek SJ. Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3. Cancer Prev Res (Phila) 2011;4:116-27. [PMID: 21205742 DOI: 10.1158/1940-6207.CAPR-10-0218] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
26 Brossard D, El Kihel L, Clément M, Sebbahi W, Khalid M, Roussakis C, Rault S. Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines. European Journal of Medicinal Chemistry 2010;45:2912-8. [DOI: 10.1016/j.ejmech.2010.03.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]